Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Range Cancer Therapeutics ETF CNCR

The investment seeks to track the total return performance, before fees and expenses, of the Loncar Cancer Immunotherapy Index. The index is composed of the common stock of approximately 25 pharmaceutical or biotechnology companies identified by the funds index provider, as having a high strategic focus on the development of drugs that harness the bodys own immune system to fight cancer. The... see more

Recent & Breaking News (NDAQ:CNCR)

    EXCHANGE TRADED CONCEPTS, LLC., ANNOUNCES COMPLETION OF FUND REORGANIZATION

    PR Newswire October 23, 2023

    Loncar China BioPharma ETF (CHNA) Launches on Nasdaq

    Business Wire August 15, 2018

    Loncar Cancer Immunotherapy Index Announces Merger Replacements

    Business Wire October 4, 2017

    Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

    Business Wire June 21, 2017

    Cancer Immunotherapy ETF (Nasdaq: CNCR) to Ring the Nasdaq Stock Market Opening Bell

    GlobeNewswire October 28, 2016

    Cancer Immunotherapy ETF Celebrates One-Year Anniversary

    Business Wire October 14, 2016

    Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

    Business Wire June 22, 2016

    Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

    Business Wire December 16, 2015

    Loncar Investments Selects Cancer Research Institute as Exclusive Charitable Partner in Immunotherapy Research Donation Program

    Business Wire December 1, 2015